GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinotherapeutics Inc (SHSE:688247) » Definitions » Deferred Tax

Sinotherapeutics (SHSE:688247) Deferred Tax : ¥0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Sinotherapeutics Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Sinotherapeutics's change in deferred tax for the three months ended in Mar. 2024 was ¥0.0 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.0 Mil.

Sinotherapeutics Deferred Tax Historical Data

The historical data trend for Sinotherapeutics's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinotherapeutics Deferred Tax Chart

Sinotherapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial - - - - -

Sinotherapeutics Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sinotherapeutics Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sinotherapeutics Deferred Tax Related Terms

Thank you for viewing the detailed overview of Sinotherapeutics's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinotherapeutics (SHSE:688247) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinotherapeutics Inc (SHSE:688247) » Definitions » Deferred Tax
Comparable Companies
SHSE:603520 SZSE:300485 SZSE:300110 SZSE:002644 SHSE:688566 SHSE:688073 SZSE:300194 SHSE:600488 SZSE:002393 SZSE:002728 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 515 Huanke Road, Room 205 and 207, Pilot Free Trade Zone, Shanghai, CHN, 201203
Website
http://www.sinotherapeutics.com
Sinotherapeutics Inc is engaged in the research and development, production and sales of generic drugs and CRO services.

Sinotherapeutics (SHSE:688247) Headlines

No Headlines